Clinical Trials Browser

Ototoxicity × Cisplatin × Clear all

NCT05756660 2025-10-20

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

Phase EARLY_PHASE1 Suspended

Gastrointestinal

Ototoxicity, Neoplasms, Germ Cell and Embryonal, Hepatoblastoma

NCT00652132 2018-05-29

SIOPEL6

Phase 3 Completed

116 enrolled 1 FDA

Gastrointestinal

Ototoxicity, Liver Neoplasms, Hepatoblastoma

NCT02382068 2017-11-09

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Phase NA Withdrawn

Ototoxicity, Neoplasms